- Who can participate: Adults aged 18 to 65 years who have been diagnosed with chronic pain for at least six months may be eligible to participate. Key eligibility factors include a stable medication regimen for managing pain and no history of adverse reactions to similar treatments.
- Study details: Participants will receive either the investigational treatment or a placebo. The study is double-blind, meaning neither the participants nor the researchers will know who is receiving the treatment or placebo. Participants will be required to attend regular clinic visits and complete questionnaires about their pain levels and overall health.
How understandable was the trial content above?
Hard to understand
Easy to understand